RAJ NARAN TO SUCCEED GREG KILMISTER AS ALS BOSS

RAJ NARAN TO SUCCEED GREG KILMISTER AS ALS BOSS
GREG Kilmister (pictured) will retire as MD and CEO of ALS Limited (ASX: ALQ) after 36 years with the company and 12 as its CEO.

Following the ALS annual general meeting on 20 July, Kilmister will be replaced by the current head of the company's Life Sciences division, Raj Naran.

Under Kilmister's leadership, the Brisbane-based company, which was formerly known as Campbell Brothers, entered the ASX100 as it grew from a market capitalisation of $381 million in 2005 to $3.1 billion today.

"It has been a privilege to lead an exceptional team of talented people in building ALS from 4,000 staff in 2005 to in excess of 13,000 today," says Kilmister.

Naran, who will remain based in Houston, is now deputy CEO and will work with Kilmister on the handover in coming months. He has been leading a review of the company's five-year strategic plan as part of the succession process and that will continue until his appointment on 20 July.

The company says Naran will travel to Australia "as required to perform his duties".

The appointment comes after a nine-month recruitment and selection process that included a major global talent search conducted with Korn Ferry Group.

ALS chairman Bruce Phillips says, "We are delighted an ALS executive so strongly committed to the company's culture has emerged as the best candidate to succeed Greg."

Naran founded e-Lab Analytical, an environmental analytical testing business based in Texas and Michigan, which was acquired by ALS in 2007.

He was later appointed to lead ALS' USA Environmental business and grew his role to lead the global Life Sciences division.

The Life Sciences division has increased revenue from $165 million to $634 million under Naran's leadership, and increased earnings before interest and tax from $24 million to $110 million.

"Raj's leadership qualities have been well demonstrated during the significant growth of the Life Sciences division. His strong focus on profitability and delivering on customer needs, through both organic growth and M&A activity have delivered substantial gains for ALS shareholders," says Phillips.

"ALS is a unique Australian company and I have every confidence that Raj will lead the company to an even brighter future. I look forward to working with Raj and the board to ensure a smooth transition in the months ahead."

ALS is trading steady on the ASX this morning at $5.94 per share.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

From pandemic side hustle to multi-million dollar business: Meet Ling Fung
Partner Content
Ask any parent, and they’ll tell you: preparing for a new baby is no easy task.&n...
Metro Baby
Advertisement

Related Stories

King-hits keep coming for The Star as AUSTRAC launches civil enforcement action

King-hits keep coming for The Star as AUSTRAC launches civil enforcement action

The king-hits keep coming for Star Entertainment Group (ASX: SGR) w...

Is attribution software killing our creativity?

Is attribution software killing our creativity?

As digital marketing continues to evolve at rapid speeds, businesse...

Sonic Healthcare acquires 20pc stake in gut health business Microba Life Sciences

Sonic Healthcare acquires 20pc stake in gut health business Microba Life Sciences

Global medical diagnostics giant Sonic Healthcare (ASX: SHL) has ag...

Collins Foods pauses Taco Bell roll-out amidst $16.9m impairment crunch

Collins Foods pauses Taco Bell roll-out amidst $16.9m impairment crunch

Australia's largest operator of KFC restaurants has struggled t...